$12.690
-0.039 (-0.31%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
NTLA 相似圖表分析預測
Alphio's NTLA stock price prediction model matches the current Intellia Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.78 (+0.74%). The 1-week path is $12.98 (+2.36%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Intellia Therapeutics Inc 股票嗎？
Intellia Therapeutics Inc is currently priced at $12.87, which is below the average analyst price target of $17, indicating potential upside. However, the company has a negative net income of -106634000 USD in Q2 2026 and a concerning insider selling increase of 2235.78%, which raises risks for investors. Given these mixed signals, it's prudent to hold rather than buy at this time.
NTLA 股價於 Tuesday 收在 $12.69，此前下跌 -0.31%
Intellia Therapeutics Inc (NTLA) last closed at $12.685, losing -0.35%. These facts feed the 1-day and 1-week NTLA price prediction above.
分析師一致預期
Intellia Therapeutics Inc（NTLA）：買進 4、持有 2、賣出 0。展望：Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
Intellia Therapeutics Inc（NTLA）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
相似圖表形態
近期走勢與 NTLA 最接近的股票，依相似度排序。
NTLA 季節性分析
Historically the probability of a positive September return for NTLA is 28.57%. October offers the highest probability of a positive month at 50.00%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。